NC/DS 38779224904 $290.86
KETOROLAC TROMETHAMINE 5GM PWD DS KETOROLAC TROMETHAMINE LETCO MEDICAL LLC/DS 62991281801 $92.41
KETOROLAC TROMETHAMINE DS PWD 5GM KETOROLAC TROMETHAMINE MEDISCA INC/DS 38779224903 $93.26
KETOROLAC TROMETHAMINE USP PWD 100 GM DS KETOROLAC TROMETHAMINE MEDISCA INC/DS 38779224905 $1,316.18
ACULAR LS 0.4 % SOL 5 ML KETOROLAC TROMETHAMINE ALLERGAN USA INC. 23927705 $535.24
ACUVAIL 0.45 % VL 30 KETOROLAC TROMETHAMINE/PF ALLERGAN USA INC. 23350730 $982.04
KETOROLAC TROMETHAMINE 0.5% O/S 5 ML KETOROLAC TROMETHAMINE SUN PHARMACEUTICAL IND INC 47335022090 $181.99
KETOROLAC 30 MG SDV 25X1 ML KETOROLAC TROMETHAMINE SAGENT PHARMACEUTICALS INC 25021070101 $387.44
KETOROLAC 30 MG-1ML FILL-2ML SDV 25X1 ML KETOROLAC TROMETHAMINE HOSPIRA WORLDWIDE INC. 409379501 $401.15
KETOROLAC TRO 30 MG-ML SDV 25X1 ML KETOROLAC TROMETHAMINE FRESENIUS KABI USA LLC 63323016201 $403.80
OMIDRIA 1%/0.3% 4ML SDV 4/PAC PHENYLEPHRINE/KETOROLAC OMEROS CORPORATION 62225-0600-04 $3,525.00
KETOROLAC TRO 0.5% OPH SOL 5 ML KETOROLAC TROMETHAMINE SANDOZ/FALCON PHARMA LTD 61314012605 $176.69
KETOROLAC TRO 15 MG-ML SDV 25X1 ML KETOROLAC TROMETHAMINE HOSPIRA WORLDWIDE INC. 409379301 $323.10
---------------------------------------------------------------
KETOROLAC TROMETHAMINE- ketorolac tromethamine injection
Pfizer Laboratories Div Pfizer Inc
Each mL of Ketorolac Tromethamine Ophthalmic Solution contains: Active: Ketorolac tromethamine 0.4%. Preservative: Benzalkonium chloride 0.006%. Inactives: Edetate disodium dihydrate 0.015%; octoxynol 40; sodium chloride; hydrochloric acid and/or sodium hydroxide to adjust the pH; and water for injection.
TORADOL ORAL (ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults), management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following IV or IM dosing of ketorolac tromethamine, if necessary. The total combined duration of use of TORADOL ORAL and ketorolac tromethamine should not exceed 5 days.
Rx Only
WARNING
Ketorolac Tromethamine Injection USP, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults), management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following IV or IM dosing of ketorolac tromethamine, if necessary. The total combined duration of use of oral ketorolac tromethamine and ketorolac tromethamine injection should not exceed 5 days.
Ketorolac tromethamine is not indicated for use in pediatric patients and it is NOT indicated for minor or chronic painful conditions. Increasing the dose of oral ketorolac tromethamine beyond the label recommendations will not provide better efficacy but will increase the risk of developing serious adverse events.
GASTROINTESTINAL RISK
Ketorolac tromethamine can cause peptic ulcers, gastrointestinal bleeding and/or perforation of the stomach or intestines, which can be fatal. These events can occur |
